Skip to content
Recall Observatory FDA recall evidence

Drug product

CABTREO (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel 1.2%/0.15%/3.1%, Not for Oral, Ophthalmic or Intravaginal Use, Rx Only, Net Wt. 50g, Distributed by Bausch Health US, LLC Bridgewater, NJ 08807 USA, Manufactured by: Bausch Health Companies, Inc. Laval Quebec H7L 448, Canada, NDC 0187-0006-25.

D-0347-2024

February 12, 2024

Class II

Product summary

Firm
MCKESSON CORPORATION
Event
Event 94023
Status
Terminated
Classification
Class II
Quantity
42 units
Official record key
drug-enforcement:D-0347-2024

Official wording

Reason: CGMP Deviations: Product was stored outside labeled storage temperature requirements. Product was exposed to controlled room temperature environment instead of remaining refrigerated.

Code information: Lot: 7001796, Exp 05/31/2025

Distribution pattern: Nationwide in the US

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations